Evidence map›Paper›PMID 37967641›Full record

ArticleAmerican heart journal2024

Testing interventions to reduce clinical inertia in the treatment of hypertension: rationale and design of a pragmatic randomized controlled trial.

Nancy Haff, Sushama Kattinakere Sreedhara, Wendy Wood, Elad Yom-Tov, Daniel M Horn, Melissa Hoover, Greg Low, Julie C Lauffenburger, Alexander Chaitoff, Massimiliano Russo and 4 more

Registry-linked trialOpen access · greenAbstract readClinical Trial Protocol
In one paragraph

Article in American heart journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04603560 (Personalizing Intervention to Reduce Clinical Inertia in the Treatment of Hypertension), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04603560 nacompletednot on this map

Personalizing Intervention to Reduce Clinical Inertia in the Treatment of Hypertension

TypeinterventionalSponsorBrigham and Women's HospitalRan2021 to 2023Enrolled511ConditionsHypertensionArmsAudit and Feedback, Pharmacist E-Detailing
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Nancy HaffCenter for Healthcare Delivery Sciences (C4HDS), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: nhaff@partners.org.
Sushama Kattinakere SreedharaCenter for Healthcare Delivery Sciences (C4HDS), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Wendy WoodDepartment of Psychology & Marshall School of Business, University of Southern California, Los Angeles, CA.
Elad Yom-TovMicrosoft Research, Herzliya, Israel.
Daniel M HornDepartment of Medicine, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA.
Melissa HooverMass General Physicians Organization, Massachusetts General Hospital, Boston, MA.
Greg LowMass General Physicians Organization, Massachusetts General Hospital, Boston, MA.
Julie C LauffenburgerCenter for Healthcare Delivery Sciences (C4HDS), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
Alexander ChaitoffCenter for Healthcare Delivery Sciences (C4HDS), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
Massimiliano RussoCenter for Healthcare Delivery Sciences (C4HDS), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
Kaitlin HankenCenter for Healthcare Delivery Sciences (C4HDS), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Katherine L CrumCenter for Healthcare Delivery Sciences (C4HDS), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Constance P FontanetCenter for Healthcare Delivery Sciences (C4HDS), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Niteesh K ChoudhryCenter for Healthcare Delivery Sciences (C4HDS), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Brigham and Women's Hospital · USMassachusetts General Hospital · USHarvard University · USMicrosoft (Israel) · ILUniversity of Southern California · US

Funding

The Roybal Center for TherapeuticOptimization using BehavioralScienceP30AG064199 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI Julie Christine Lauffenburger · 2019 to 2026
$8.3M
Development of an implementation-ready antihypertensive self-titration intervention to improve US blood pressure controlK23HL161480 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Nancy Haff · 2022 to 2026
$826k
Development of a novel medication adherability tool to improve cardiovascular disease managementK01HL141538 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LAUFFENBURGER, JULIE CHRISTINE · 2018 to 2022
$718k
NHLBI NIH HHS K01 HL141538NHLBI NIH HHS K23 HL161480NIA NIH HHS P30 AG064199
6 · The paper itself

Abstract

backgroundClinical inertia, or failure to intensify treatment when indicated, leads to suboptimal blood pressure control. Interventions to overcome inertia and increase antihypertensive prescribing have been modestly successful in part because their effectiveness varies based on characteristics of the provider, the patient, or the provider-patient interaction. Understanding for whom each intervention is most effective could help target interventions and thus increase their impact.

methodsThis three-arm, randomized trial tests the effectiveness of 2 interventions to reduce clinical inertia in hypertension prescribing compared to usual care. Forty five primary care providers (PCPs) caring for patients with hypertension in need of treatment intensification completed baseline surveys that assessed behavioral traits and were randomized to one of three arms: 1) Pharmacist e-consult, in which a clinical pharmacist provided patient-specific recommendations for hypertension medication management to PCPs in advance of upcoming visits, 2) Social norming dashboards that displayed PCP's hypertension control rates compared to those of their peers, or 3) Usual care (no intervention). The primary outcome was the rate of intensification of hypertension treatment. We will compare this outcome between study arms and then evaluate the association between characteristics of providers, patients, their clinical interactions, and intervention responsiveness.

resultsForty-five primary care providers were enrolled and randomized: 16 providers and 173 patients in the social norming dashboards arm, 15 providers and 143 patients in the pharmacist e-consult arm, and 14 providers and 150 patients in the usual care arm. On average, the mean patient age was 64 years, 47% were female, and 73% were white. Baseline demographic and clinical characteristics of patients were similar across arms, with the exception of more Hispanic patients in the usual care arm and fewest in the pharmacist e-consult arm.

conclusionsThis study can help identify interventions to reduce inertia in hypertension care and potentially identify the characteristics of patients, providers, or patient-provider interactions to understand for whom each intervention would be most beneficial.

trial registrationClinicaltrials.gov (NCT, Registered: NCT04603560).

Indexed as

Antihypertensive AgentsHypertensionBlood PressureFemaleHumansMaleMiddle AgedPragmatic Clinical Trials as TopicRandomized Controlled Trials as TopicAntihypertensive Agents

Identifiers

PMID37967641
PMCPMC10843752
OpenAlexW4388668239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.